Study shows muted stress response linked to long-term cannabis use

July 31, 2017
WSU researchers Carrie Cuttler and Ryan McLaughlin. Credit: WSU

A new study by Washington State University psychology researchers reveals a dampened physiological response to stress in chronic cannabis users.

Using a nationally recognized procedure designed to provoke elevated levels of , Carrie Cuttler, clinical assistant professor of psychology, Ryan McLaughlin, assistant professor of integrative physiology and neuroscience, and colleagues in the WSU Department of Psychology examined levels of the in both chronic cannabis users and non-users.

"To the best of our knowledge, this is the first study to examine the effects of acute stress on salivary cortisol levels in chronic cannabis users compared to non-users," Cuttler said. "While we are not at a point where we are comfortable saying whether this muted stress response is a good thing or a bad thing, our work is an important first step in investigating potential therapeutic benefits of cannabis at a time when its use is spreading faster than ever before."

The WSU researchers found virtually no difference in the salivary cortisol levels of two groups of heavy cannabis users confronted with either a psychologically and physiologically stressful situation or a non-stressful one.

In contrast, cortisol levels among non-users of cannabis who experienced the same simulated stressful situation were found to be much greater than the cortisol level of non-users in the no-stress scenario.

The findings are consistent with a growing body of literature that indicates chronic cannabis use is associated with dulled adrenal and emotional reactivity. The study was published recently in the journal Psychopharmacology.

The

Research participants self-identified as either a chronic cannabis consumer, with daily or nearly daily use for the previous year, or as a non-user who had consumed cannabis 10 or fewer times in their life and not at all within the previous year. Forty daily cannabis users and 42 non-users participated in the study. All were required to abstain from consuming cannabis on the day of testing.

Upon arrival at the lab, participants provided a saliva sample and were asked to rate their current level of stress. The chronic cannabis users and non-users were randomly assigned to experience either the high-stress or no-stress version of the Maastricht Acute Stress Test. Known by its acronym MAST, it is a commonly used procedure for stress-related research which combines elements of physical, psychosocial and unpredictable types of stress.

The no-stress version was simple: participants placed one hand in lukewarm water for 45-90 seconds and then were asked to count from 1 to 25.

The high-stress version upped the stakes significantly. Participants placed their hand in ice cold water for 45-90 seconds. They were then asked to count backwards from 2043 by 17 and were given negative verbal feedback when they made a mistake. On top of this, subjects were monitored by a web camera and the video feed was displayed on a screen directly in front of the participants so they couldn't help but see themselves.

Immediately following the stress manipulation, all participants once again provided a saliva sample and were asked to rate their current level of stress. Before departing the testing facility, participants also provided a urine sample so researchers could corroborate self-reported use with bodily THC levels.

Interpreting the results

Cuttler and her colleagues' work suggests cannabis may have benefits in conferring resilience to stress, particularly in individuals who already have heightened emotional reactivity to stressful situations.

However, the researchers emphasized the release of cortisol typically serves an adaptive purpose, allowing an individual to mobilize energy stores and respond appropriately to threats in the environment.

"Thus, an inability to mount a proper hormonal response to stress could also have detrimental effects that could potentially be harmful to the individual," Cuttler said. "Research on cannabis is really just now ramping up because of legalization and our work going forward will play an important role in investigating both the short-term benefits and potential long-term consequences of chronic cannabis use."

Next steps in the research will include investigating various factors, such as the presence of residual THC, which may be influencing the muted stress response in .

Explore further: Stress hormone linked to mood and hippocampus volume

More information: Carrie Cuttler et al, Blunted stress reactivity in chronic cannabis users, Psychopharmacology (2017). DOI: 10.1007/s00213-017-4648-z

Related Stories

Stress hormone linked to mood and hippocampus volume

July 24, 2017
Individual differences in the pattern of release of the hormone cortisol in response to a stressful experience reveal how stressed a person actually feels, suggests a study of healthy women published in The Journal of Neuroscience. ...

Low-dose THC can relieve stress; more does just the opposite

June 2, 2017
Cannabis smokers often report that they use the drug to relax or relieve stress, but few studies provide clinical evidence of these effects.

Do cannabis users think package warnings are needed?

December 6, 2016
Legalization of cannabis for medical or leisure use is increasing in the U.S., and many experts and cannabis users alike agree that package warnings stating the health risks are needed. The warnings suggested by cannabis ...

Concern with potential rise in super-potent cannabis concentrates

July 21, 2017
University of Queensland researchers are concerned the recent legalisation of medicinal cannabis in Australia may give rise to super-potent cannabis concentrates with associated harmful effects.

Questions remain about the benefits and harms of cannabis

April 3, 2017
Despite dramatic changes in the legal landscape and usage rates of cannabis, evidence is still lacking regarding its potential health and therapeutic effects. Recently, the National Academies of Sciences, Engineering, and ...

Study adds to evidence that high strength cannabis is associated with an increased risk of becoming dependent

October 22, 2016
New data presented at this year's International Early Psychosis Association (IEPA) meeting in Milan, Italy (20-22 October) adds to accumulating evidence that high-potency cannabis in associated with an increased risk of users ...

Recommended for you

Before assigning responsibility, our minds simulate alternative outcomes, study shows

October 17, 2017
How do people assign a cause to events they witness? Some philosophers have suggested that people determine responsibility for a particular outcome by imagining what would have happened if a suspected cause had not intervened.

Schizophrenia disrupts the brain's entire communication system, researchers say

October 17, 2017
Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

For older adults, volunteering could improve brain function

October 17, 2017
Older adults worried about losing their cognitive functions could consider volunteering as a potential boost, according to a University of Missouri researcher. While volunteering and its associations with physical health ...

Magic mushrooms may 'reset' the brains of depressed patients

October 13, 2017
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Living near a forest keeps your amygdala healthier

October 13, 2017
A study conducted at the Max Planck Institute for Human Development has investigated the relationship between the availability of nature near city dwellers' homes and their brain health. Its findings are relevant for urban ...

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.